Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MacroArray Technologies was a biotechnology company specializing in the development of high-throughput diagnostic tools for allergy testing. The company's primary offering was a proprietary microarray platform designed to detect allergen-specific IgE antibodies in human serum. This technology allowed for the simultaneous screening of hundreds of individual allergens using a single, small blood sample, providing a comprehensive profile of a patient's sensitivities. By multiplexing the diagnostic process, the company aimed to offer a more efficient and cost-effective alternative to traditional single-plex blood tests and skin prick testing. Based at the HudsonAlpha Institute for Biotechnology in Alabama, MacroArray Technologies focused on serving clinical laboratories and the broader healthcare market before ceasing operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MacroArray Technologies.